


ARTCURE Revenue
Hospitals and Health Care • Türkiye • 1-10 Employees
ARTCURE revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at ARTCURE
Marty Cure
owner
Company overview
| Headquarters | Türkiye |
| Website | |
| NAICS | 62 |
| SIC | 356 |
| Employees | 1-10 |
About ARTCURE
MT Sağlık Ürünleri, which started its activities in the field of health on August 8, 2005, brought mobility and quality to the health sector from the first day. It broke the established patterns and started to offer the world's best and quality brands at standard prices to people living all over Turkey and became the leading company of the sector in a short time. MT Sağlık Ürünleri, whose mission is to bring the latest developments in the world health sector, the most advanced technology, with a wide range and standard price policy, to the people in need, working in cooperation with the world's most important brands in the health sector, besides their quality approved products, their superior technologies. to become an important actor in the health sector, not only in Turkey but also all over the world. Mt Sağlık is the only authorized company responsible for all sales rights of the ARTCURE® PW Diffusional Patch . ARTCURE® PW Diffusional Patch - NON-INVASIVE METHOD IN DISK HERNIATION TREATMENT Combination of the words ART and CURE, ARTCURE® is a new system which will change the existing treatment protocols and do it deeply and naively without damaging, just like making art. ARTCURE® is the only product applied transdermally which ensures relieve on the pressure on the spinal line by making the disc herniation smaller than the body mass thanks to its mechanical effect. With its designated ARTCURE® carrier, ARTCURE® components reaching nucleus pulposus (herniated disc) ensure that the water inside the nucleus pulposus (which is approximately 80% in volume) is bulged out; therefore, mass of the herniated nucleus pulposus is significantly reduced. Once the nucleus pulposus becomes lighter, it makes less pressure on the nerve root and spine itself. This in return significantly relieves the patient’s pain. Patients do not require presenting an MR to apply ARTCURE®.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
ARTCURE has never raised funding before.
Frequently asked questions
4.8
40,000 users



